Shuttle Pharmaceuticals Holdings, Inc. (SHPH)

Price, with every insider trade on it

Closing prices, 12 months · point at a dot for who traded, or at the line for the close

5.33 on 9 Oct 2026

6 buys5 sales at will0 planned sales

Fiscal year 2025, ended 31 Dec 2025, as filed

Net income

$11.72M

Free cash flow

$9.48M

Return on equity

-519.9%

Return on capital

-401.4%

Debt to equity

0.04

Fiscal years, as filed with the SEC · point at a year for the detail

RevenueNet incomeLoss

From Form 4, most recent first

Date	Insider	Type	Value	Of own stake
14 Jul 2026	HRT FINANCIAL LP 10% owner	Sold at will	$367.88K	100%
13 Jul 2026	HRT FINANCIAL LP 10% owner	Sold at will	$4.82K	1.7%
10 Jul 2026	HRT FINANCIAL LP 10% owner	Bought	$2.27K	1.2%
9 Jul 2026	HRT FINANCIAL LP 10% owner	Bought	$27.94K	15.8%
8 Jul 2026	HRT FINANCIAL LP 10% owner	Sold at will	$65.23K	26.2%
7 Jul 2026	HRT FINANCIAL LP 10% owner	Sold at will	$35.23K	13.0%

34out of 100

Profitability 0

Financial strength 55

Growth n/a

Insiders 57

Strongest on insiders (57), weakest on profitability (0). A score of the business, not of the price.

Last 12 months

Only here

Bought

$181.76K

6 buys, 1 buyer

Sold

$504.83K

5 sales

Planned sales

under a 10b5-1 plan